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Abstract 
Alopecia areata is a common cause of noncicatricial alopecia that occurs in a patchy, 
confluent or diffuse pattern. It may occur as a single, self-limiting episode or may recur at 
varying intervals over many years. The association of alopecia areata with localized 
vitiligo has not been reported. The association of alopecia areata with localized vitiligo in 
the same patient is documented here; it is the first of its kind. 
Introduction 
Alopecia areata manifests as loss of hair on a hairy part of the skin, such as the scalp, 
beard, mustache, etc., which may be patchy, confluent or diffuse in pattern. It may occur 
as a single, self-limiting episode or may recur at varying intervals over many years [1]. 
Strong direct and indirect evidence supports an autoimmune etiology for alopecia areata. 
The origin of the disease process is not fully understood; however, there are indications 
for a T cell-mediated autoimmune process directed against an unknown autoantigen of 
the hair follicle. T lymphocytes that have been shown to be oligoclonal and autoreactive 
are predominantly present in the peribulbous inflammatory infiltrate [2]. Alopecia areata 
frequently occurs in association with other autoimmune disorders such as generalized 
vitiligo, lichen planus, morphea, lichen sclerosus et atrophicus, pemphigus foliaceus, 
atopic dermatitis, Hashimoto’s thyroiditis, hypothyroidism, endemic goiter, Addison’s 
disease, pernicious anemia, lupus erythematosus, diabetes mellitus, Down’s syndrome 
and others [3, 4]. 
Case Report 
A 15-year-old girl presented with loss of hair since 4 years. She complained of loss of hair over the 
frontal area of the scalp and over the posterior aspect of the scalp above the neck region. She 
complained of depigmented lesions since 7 months on the right and left leg.  
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On examination, loss of hair was seen over the frontal region of the scalp (fig. 1) and over the 
posterior region of the scalp above the neck region. Two depigmented lesions were seen on the right leg 
(fig. 2) and one on the left leg (fig. 2). There was no evidence of atopic dermatitis, neurodermatitis, 
seborrheic dermatitis, verrucae, furunculosis, lichen planus and lichen sclerosus et atrophicus. Systemic 
diseases like thyroid disorders, anemia, diabetes, allergic rhinitis and bronchial asthma, hypertension 
and ulcerative colitis were not observed in the patient. 
Discussion 
Various theories are suggested for the etiology of alopecia areata and vitiligo. The 
association of alopecia areata with seemingly unrelated autoimmune disorders has led to 
an intense search for immune derangements [5]. In vitiligo, an autoimmune hypothesis is 
suggested by its clinical association with a number of disorders considered to be 
autoimmune [5]. Vitiligo seems to occur about 4 times more often in patients with 
alopecia areata than in the general population [4]. Alopecia areata accounts for around 
2% of new dermatological outpatient attendances in Britain and the United States. 
Among the factors that appear to be implicated in etiopathogenesis are the genetic 
constitution of the patient, atopic state, nonspecific immune and organ-specific 
autoimmune reactions and possibly emotional stress [6]. Alopecia areata has been 
considered as an autoimmune disease due to an aberrant T cell response against hair 
follicle self antigens [7]. This autoimmune etiology has also been proposed on the basis of 
its association with autoimmune diseases, the presence of autoantibodies and various 
underlying immunologic abnormalities in the affected sites of these patients. Lesions in 
alopecia areata do not form and resolve in the usual sense; however, as evident by its 
chronicity and high rate of recurrence, the disease represents a continuous reactivity of 
the pilar units. The capacity of hair to react in clinically recognized patterns as alopecia 
areata is probably inherited, although the mode of inheritance, penetrance and 
expressivity of the genes must be highly variable [4]. Alopecia areata may begin as early as 
the first month of life [7, 8] or as late as in the late seventies [4]. Family history of alopecia 
areata was not present in our patient. 
Atopy has been reported to occur with an increased frequency in patients with alopecia 
areata [4, 9]. The atopic type in Ikeda’s classification of alopecia areata comprised 10% of 
1,989 patients [10]. Similarly, 11% of 736 patients with alopecia areata studied by Muller 
and Winkelmann [4] had concomitant asthma or atopic dermatitis. In our patient, there 
was no history of atopy. One of the main systemic associations of autoimmune diseases is 
with thyroid abnormalities. The incidence of thyroid disease has varied from 8–28% in 
patients with alopecia areata [11]. Lewinski et al. [12] also confirmed the frequent 
coexistence of alopecia areata and thyroid abnormalities. Conversely, in 1994, Puavilai et 
al. [13] estimated that the prevalence of thyroid disease is relatively low (7.2%), and 
patients with thyroid disease were not statistically different from patients with alopecia 
areata and the control group. Thyroid abnormalities were not seen in our patient. In one 
study, there was a high association of alopecia areata and familial generalized vitiligo [14]. 
The association of alopecia areata with localized vitiligo has not been reported. 
Vitiligo can be separated into segmental and nonsegmental types [15]. In 
nonsegmental vitiligo, there is usually symmetric distribution of lesions and new patches 
may appear throughout the patient’s life. It may be either generalized or localized. In 
generalized, nonsegmental vitiligo, there is usually widespread distribution of 
depigmented patches. Vitiligo which is so extensive that few normally pigmented patches 
remain is known as vitiligo universalis. Acrofacial vitiligo skin involvement is limited to  
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the distal digits and periorificial facial areas. Focal vitiligo lesions are limited in quantity 
and location and have a nondermatomal distribution. Focal vitiligo may develop into 
generalized vitiligo or may follow an early-stabilizing clinical course [16]. Segmental 
vitiligo has important differences in etiology, prevalence of associated illnesses and 
therapy compared to other forms of vitiligo. It usually has unilateral involvement and a 
dermatomal distribution. Segmental vitiligo is known for its early onset and rapid spread. 
Without treatment, lesions are typically persistent throughout life, but stop developing 
within 2 years of onset. Childhood vitiligo, in one survey, consisted primarily of typical 
generalized, nonsegmental vitiligo (78%), with focal vitiligo (14.4%) and segmental 
vitiligo (4.6%) being far less prevalent [17]. 
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Fig. 1. Shows loss of hair over the frontal region of the scalp. 
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Fig. 2. Shows two depigmented lesions seen on the right leg and one on the left leg. 
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